No Data
No Data
Stoke Therapeutics (STOK) Upgraded to Buy: What Does It Mean for the Stock?
$STOK Stock Is up 10% Today. Here's What We See in Our Data.
Stoke Therapeutics Analyst Ratings
Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $20